I am writing to you today with the utmost pleasure to introduce myself, Stephen Barnhill, Jr., as the newly appointed Interim CEO and President of Global Hemp Group, Inc. I am honored to have been chosen for this role and I am thrilled to be joining such an innovative and forward-thinking company.
I am a seasoned C-level executive with nearly a decade of experience in the natural biologics drug discovery industry with a track record of success as a co-founder and executive officer leading international companies, both private and publicly traded, in the United States, the United Kingdom and the Caribbean.
While I am excited about the potential of hemp as a sustainable and eco-friendly alternative to traditional materials, I am passionate about developing natural biologic medicines to help patients globally, particularly patients with cancer, chronic pain and inflammatory diseases such as Alzheimer’s and Parkinson’s and look forward to bringing my expertise and vision to Global Hemp Group as we now expand the business into the BioPharma space. I am enthusiastic about moving the company forward on both fronts.
GHG’s recent acquisition of the exclusive rights to the Apollon Formularies, plc intellectual property and patents in the United States, Canada, Mexico, Israel, and the European Union (with extension to Morocco) provides the company with a great opportunity to generate near term revenue through sublicensing deals with legally licensed manufacturers, distributors and retailers in these countries.
In the links provided below, there are a number of articles written specifically about the intellectual property that has been exclusively licensed by GHG from Apollon Formularies, plc. I hope you will take a few minutes to read them, as I believe you will find them quite interesting and they should help you understand the revenue opportunities that these exclusive licenses provide to GHG in the various countries where the IP has been protected.
Apollon Formularies Cannabis Formulations Show Early Promise in Prostate Cancer
Cannabis and Mushrooms and Their Tale to Treating Cancer
Apollon Formularies Cannabis Products Effective at Killing Prostate Cancer
Medical Marijuana Soars to New Heights
As we move forward, I want to assure you that I am committed to maintaining the company's focus on sustainability, innovation, and social responsibility. In addition, I believe that by internationally sublicensing these patent protected effective therapeutics from Apollon’s artificial intelligence-based discovery platform which identifies the unique formulations of cannabinoids, terpenes, flavonoids, medicinal, and psychedelic mushrooms compounds, as well as specific molecules from other natural plants and herbs, we can provide efficacious therapeutic products for patients and their physicians around the world. In simpler terms, our company intends to provide products created by utilizing the power of state-of-the-art artificial intelligence techniques to unlock the secrets in ancient remedies that have stood the test of time. Thereby, creating an opportunity to provide effective natural biologic therapeutics globally.
In the coming months, my team and I will be working hard to develop a strategic plan that will guide the company's growth and success. We will be exploring new partnerships and opportunities, as well as investing in research and development to ensure that we remain at the forefront of this industry.
I recently welcomed our new Chief Scientific Advisor, Dr. Herb Fritsche, a world-renowned expert in cancer diagnostics and former Professor and Chief of Clinical Chemistry at MD Anderson Cancer Center for 41 years and someone I have had the pleasure of working with for the past 10 years in natural biologics drug discovery. In addition, we will look to add several new scientific and medical experts to our team in the coming weeks.
I look forward to getting to know you in the coming weeks and months. Thank you for your continued support and investment in Global Hemp Group Inc. Together, I believe, we can build a successful company based on Benjamin Franklin’s premise of “doing well by doing good”.
Sincerely,
Stephen Barnhill, Jr.
CEO, Global Hemp Group Inc.